Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julja Burchard

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|February 25, 2015
The genome as pharmacopeia: association of genetic dose with phenotypic responseSamir Wadhawan, Heiko Runz, Julja Burchard
Obstetrics and Gynecology|April 26, 2020
In ReplyGeorge R Saade, J Jay Boniface, Julja Burchard
Obstetrics and Gynecology|November 26, 2019
Effects of Selective Exclusion of Patients on Preterm Birth Test PerformanceJ Jay Boniface, Julja Burchard, George R Saade
Obstetrics and Gynecology|March 29, 2020
In ReplyGeorge R Saade, J Jay Boniface, Julja Burchard
JCI Insight|March 30, 2017
Physiologically activated mammary fibroblasts promote postpartum mammary cancerQiuchen Guo, Jessica Minnier, Julja Burchard, et al.
Scientific Reports|May 31, 2012
siRNA off-target effects in genome-wide screens identify signaling pathway membersEugen Buehler, Aly A Khan, Shane Marine, et al.
Molecular and Cellular Biology|July 2, 2008
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulatorsGalina Gabriely, Thomas Wurdinger, Santosh Kesari, et al.
RNA (New York, N.Y.)|May 10, 2006
Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarityAimee L Jackson, Julja Burchard, Janell Schelter, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2021
Cost-Effectiveness of a Proteomic Test for Preterm Birth PredictionMichael Grabner, Julja Burchard, Chi Nguyen, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2011
Gene expression signature of c-MYC-immortalized human fibroblasts reveals loss of growth inhibitory response to TGFβMyra L Wang, Ryan Walsh, Kristin L Robinson, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|February 25, 2015
The genome as pharmacopeia: association of genetic dose with phenotypic responseSamir Wadhawan, Heiko Runz, Julja Burchard
Obstetrics and Gynecology|April 26, 2020
In ReplyGeorge R Saade, J Jay Boniface, Julja Burchard
Obstetrics and Gynecology|November 26, 2019
Effects of Selective Exclusion of Patients on Preterm Birth Test PerformanceJ Jay Boniface, Julja Burchard, George R Saade
Obstetrics and Gynecology|March 29, 2020
In ReplyGeorge R Saade, J Jay Boniface, Julja Burchard
JCI Insight|March 30, 2017
Physiologically activated mammary fibroblasts promote postpartum mammary cancerQiuchen Guo, Jessica Minnier, Julja Burchard, et al.
Scientific Reports|May 31, 2012
siRNA off-target effects in genome-wide screens identify signaling pathway membersEugen Buehler, Aly A Khan, Shane Marine, et al.
Molecular and Cellular Biology|July 2, 2008
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulatorsGalina Gabriely, Thomas Wurdinger, Santosh Kesari, et al.
RNA (New York, N.Y.)|May 10, 2006
Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarityAimee L Jackson, Julja Burchard, Janell Schelter, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2021
Cost-Effectiveness of a Proteomic Test for Preterm Birth PredictionMichael Grabner, Julja Burchard, Chi Nguyen, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2011
Gene expression signature of c-MYC-immortalized human fibroblasts reveals loss of growth inhibitory response to TGFβMyra L Wang, Ryan Walsh, Kristin L Robinson, et al.
Pageof 5